Medipacs Overview

  • Founded
  • 2004

Founded
  • Status
  • Private

  • Employees
  • 2

Employees
  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 9

Medipacs General Information

Description

Developer of non-mechanical infusion pumps designed for the delivery of drugs. The company's devices are non-mechanical infusion pumps used to deliver drugs, including biologic medications, insulin, hormones, fertility drugs, anti-coagulation drugs, and pain medication, enabling medical professionals to treat people and animals for post-surgical pain and other needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Other Devices and Supplies
Primary Office
  • 2100 North Wilmot Road
  • Suite 310
  • Tucson, AZ 85712
  • United States
+1 (520) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medipacs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 01-Feb-2022 000.00 Completed Generating Revenue
10. Equity Crowdfunding 23-Feb-2021 Cancelled Generating Revenue
9. Later Stage VC (Series C) 01-Oct-2015 00.00 000.00 Completed Generating Revenue
8. Later Stage VC (Series B) 18-Aug-2014 00.000 00.00 000.00 Completed Generating Revenue
7. Later Stage VC 01-Sep-2010 00000 00.000 Completed Generating Revenue
6. Accelerator/Incubator 11-Jun-2009 00.000 Completed Product Development
5. Early Stage VC (Series A3) 14-May-2009 00.000 00.000 000.00 Completed Product Development
4. Grant 01-Jan-2009 00000 00.000 Completed Startup
3. Early Stage VC (Series A2) 27-May-2008 $1.66M $1.78M Completed Startup
2. Angel (individual) 01-Jan-2008 $114K $114K Completed Startup
To view Medipacs’s complete valuation and funding history, request access »

Medipacs Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.00
Series A3 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series A2 5,181,958 $0.001000 8% $0.32 $0.32 1x $0.32 9.81%
Series A1 759,233 $0.001000 8% $0.15 $0.15 1x $0.15 1.44%
To view Medipacs’s complete cap table history, request access »

Medipacs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of non-mechanical infusion pumps designed for the delivery of drugs. The company's devices are non-mechanical
Drug Delivery
Tucson, AZ
2 As of 2018
000.00
0000000000 0 000.00

000000

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
0000 00000000
Hellebaek, Denmark
0 As of 0000
00.000
0000000000 0 00.000

00000

re et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ul
00000000000 0000000
Luzern, Switzerland
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medipacs Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Subcuject Venture Capital-Backed Hellebaek, Denmark 0 00.000 0000000000 0 00.000
00000 0000000000 Venture Capital-Backed Luzern, Switzerland 00 00000 00000000000 00000
000000 0000000000 Venture Capital-Backed Cincinnati, OH 000 00000 00000000000 00000
000000 Private Equity-Backed La Verpilliere, France 0000 000000000 00
0000000000 Corporate Backed or Acquired Stuttgart, Germany 000 000000&0
You’re viewing 5 of 10 competitors. Get the full list »

Medipacs Patents

Medipacs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2885859-A1 Low profile infusion pump with anti drug diversion and active feedback mechanisms Inactive 26-Sep-2011 00000000000
EP-2760497-A1 Low profile infusion pump with anti drug diversion and active feedback mechanisms Inactive 26-Sep-2011 00000000000
EP-2760497-A4 Low profile infusion pump with anti drug diversion and active feedback mechanisms Inactive 26-Sep-2011 00000000000
US-20140221913-A1 Low profile infusion pump with anti drug diversion and active feedback mechanisms Inactive 26-Sep-2011 00000000000
EP-2531549-A1 High surface area polymer actuator with gas mitigating components Inactive 01-Feb-2010 F03G7/005
To view Medipacs’s complete patent history, request access »

Medipacs Executive Team (12)

Name Title Board Seat Contact Info
Mark Banister Founder, Chief Executive Officer, Chief Technology Officer & Board Member
Douglas Nutter Chief Marketing Officer
Wendy Berke Director, Clinical Affairs
You’re viewing 3 of 12 executive team members. Get the full list »

Medipacs Board Members (5)

Name Representing Role Since
Harry George III Self Chairman 000 0000
Mark Banister Medipacs Founder, Chief Executive Officer, Chief Technology Officer & Board Member 000 0000
Michael Kamdar Self Chairman 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Medipacs Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medipacs Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EvoNexus Accelerator/Incubator Minority 000 0000 000000 0
HOTVentures Venture Capital Minority 000 0000 000000 0
Arizona Center for Innovation Accelerator/Incubator 000 0000 000000 0
Desert Angels Angel Group Minority 000 0000 000000 0
DO NOT PUBLISH Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »